Test Research, Inc. (TPE:3030)
Taiwan · Delayed Price · Currency is TWD 285.00
-4.50 (-1.55%)
Aug 19, 2026, 1:30 PM CST
Test Research Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,537 | 8,467 | 6,356 | 4,435 | 6,709 | 5,607 | |
Revenue Growth | 28.25% | 33.22% | 43.31% | -33.89% | 19.66% | 13.25% |
Cost of Revenue | 3,901 | 3,527 | 2,572 | 1,804 | 2,860 | 2,559 |
Gross Profit | 5,636 | 4,941 | 3,784 | 2,631 | 3,849 | 3,048 |
Selling, General & Admin | 1,435 | 1,303 | 1,175 | 1,000 | 1,154 | 995.24 |
Research & Development | 745.6 | 640.19 | 573 | 428.17 | 534.9 | 497.04 |
Operating Expenses | 2,178 | 1,949 | 1,755 | 1,422 | 1,695 | 1,490 |
Operating Income | 3,457 | 2,992 | 2,029 | 1,208 | 2,153 | 1,558 |
Interest Expense | -1.9 | -2.47 | -2.83 | -2.75 | -2.33 | -1.55 |
Interest & Investment Income | 14.6 | 14.94 | 15.66 | 14.28 | 9.08 | 8.07 |
Earnings From Equity Investments | -19.6 | -17.04 | -13.04 | - | - | - |
Currency Exchange Gain (Loss) | 300.27 | -46.91 | 120.01 | 12.83 | 264.14 | -37.35 |
Other Non Operating Income (Expenses) | 33.52 | 24.56 | 12.99 | 8.84 | 21.78 | 25.99 |
EBT Excluding Unusual Items | 3,784 | 2,965 | 2,162 | 1,242 | 2,446 | 1,553 |
Gain (Loss) on Sale of Assets | 10.22 | 31.16 | 15.56 | 13.68 | 7.7 | 4.24 |
Pretax Income | 3,795 | 2,996 | 2,178 | 1,255 | 2,454 | 1,558 |
Income Tax Expense | 676.62 | 517.8 | 341.15 | 253.98 | 532.36 | 372.45 |
Net Income | 3,118 | 2,479 | 1,837 | 1,001 | 1,921 | 1,185 |
Net Income to Common | 3,118 | 2,479 | 1,837 | 1,001 | 1,921 | 1,185 |
Net Income Growth | 54.78% | 34.96% | 83.43% | -47.89% | 62.14% | 8.46% |
Shares Outstanding (Basic) | 236 | 236 | 236 | 236 | 236 | 236 |
Shares Outstanding (Diluted) | 236 | 237 | 237 | 237 | 237 | 237 |
Shares Change | -0.04% | -0.02% | -0.03% | -0.10% | 0.08% | 0.01% |
EPS (Basic) | 13.20 | 10.49 | 7.78 | 4.24 | 8.13 | 5.02 |
EPS (Diluted) | 13.18 | 10.48 | 7.76 | 4.23 | 8.11 | 5.01 |
EPS Growth | 54.87% | 35.05% | 83.45% | -47.84% | 61.88% | 8.44% |
Free Cash Flow | 1,467 | 1,441 | 788.51 | 1,022 | 799.67 | 452.91 |
Free Cash Flow Per Share | 6.20 | 6.09 | 3.33 | 4.32 | 3.38 | 1.91 |
Dividend Per Share | 7.000 | 7.000 | 5.000 | 3.300 | 4.500 | 3.300 |
Dividend Growth | 40.00% | 40.00% | 51.52% | -26.67% | 36.36% | 0% |
Gross Margin | 59.09% | 58.35% | 59.54% | 59.31% | 57.37% | 54.36% |
Operating Margin | 36.25% | 35.34% | 31.93% | 27.25% | 32.10% | 27.79% |
Profit Margin | 32.69% | 29.27% | 28.90% | 22.58% | 28.64% | 21.14% |
Free Cash Flow Margin | 15.38% | 17.02% | 12.41% | 23.04% | 11.92% | 8.08% |
EBITDA | 3,628 | 3,158 | 2,186 | 1,319 | 2,262 | 1,669 |
EBITDA Margin | 38.04% | 37.30% | 34.40% | 29.75% | 33.72% | 29.76% |
D&A For EBITDA | 170.09 | 165.83 | 156.87 | 111.09 | 108.89 | 110.59 |
EBIT | 3,457 | 2,992 | 2,029 | 1,208 | 2,153 | 1,558 |
EBIT Margin | 36.25% | 35.34% | 31.93% | 27.25% | 32.10% | 27.79% |
Effective Tax Rate | 17.83% | 17.28% | 15.67% | 20.23% | 21.70% | 23.91% |